Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Rheumatic heart disease (RHD) and acute rheumatic fever (ARF) necessitate patient registers for effective management.
• Preventing ARF recurrences is critical to reduce RHD progression and associated morbidity.

Purpose of the Study:

• To evaluate the effectiveness of different penicillin prophylaxis regimens for ARF recurrence prevention.
• To assess the practical implications of various dosing schedules for healthcare systems and patients.

Main Methods:

• Review of randomized controlled trials comparing intramuscular long-acting benzathine penicillin G (BPG) with oral penicillin.
• Analysis of guideline recommendations and consideration of compliance, logistical, and patient-centered factors.

Main Results:

• Intramuscular long-acting BPG demonstrates superior efficacy over oral penicillin in preventing ARF recurrences.
• Four-weekly BPG administration is effective when compliance is high and offers advantages in healthcare logistics and patient adherence compared to three-weekly regimens.

Conclusions:

• Long-acting injectable penicillin is the preferred method for secondary prophylaxis of ARF.
• Four-weekly BPG dosing is a viable and practical regimen, balancing efficacy with healthcare system and patient considerations.